Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Mais filtros

Base de dados
Tipo de documento
Intervalo de ano de publicação
1.
J Oleo Sci ; 73(5): 751-760, 2024.
Artigo em Inglês | MEDLINE | ID: mdl-38692897

RESUMO

A double-blind, placebo-controlled, crossover trial was performed to analyze the effects of a small amount of lysolecithin and canola oil on blood glucose levels after consuming japonica rice. Overall, 17 Japanese adult men were assigned to consume 150 g of normally cooked japonica rice (placebo group) and 150 g of japonica rice cooked with 18 mg of lysolecithin and 1.8 g of canola oil (treatment group); these lipids were added as emulsified formulation (EMF) for stability and uniformity. Subsequently, blood samples were collected before and 30, 45, 60, 90, and 120 min after consuming test foods. There was no significant difference in blood glucose, insulin, and triglyceride levels between the groups. However, a stratified analysis of 11 subjects with body mass index (BMI) ≥ 22 revealed that blood glucose levels were significantly lower after 30 min in the treatment group than in the placebo group (p = 0.041). Through in vitro digestibility test, the rice sample of the treatment group was observed to release significantly less glucose within 20 min than that in the placebo group rice. These results suggest that the combination of a small amount of lysolecithin and canola oil modulated the increase in postprandial blood glucose levels induced by the intake of cooked japonica rice in adult men with BMI ≥ 22. This clinical trial was registered with the University Hospital Medical Information Network (UMIN) Center, (UMIN000045744; registered on 15/10/2021).


Assuntos
Glicemia , Estudos Cross-Over , Oryza , Período Pós-Prandial , Óleo de Brassica napus , Humanos , Masculino , Óleo de Brassica napus/administração & dosagem , Oryza/química , Método Duplo-Cego , Glicemia/análise , Adulto , Triglicerídeos/sangue , Pessoa de Meia-Idade , Índice de Massa Corporal , Insulina/sangue , Índice Glicêmico , Fatores de Tempo , População do Leste Asiático
2.
Biochem Biophys Res Commun ; 379(2): 309-13, 2009 Feb 06.
Artigo em Inglês | MEDLINE | ID: mdl-19103155

RESUMO

A protease was purified from the culture medium of Clostridium botulinum serotype C strain Stockholm (C-St). The purified protease belonged to the cysteine protease family based on assays for enzyme inhibitors, activators and kinetic parameters. The protease formed a binary complex consisting of 41- and 17-kDa proteins held together non-covalently. The DNA sequence encoding the protease gene was shown to be a single open reading frame of 1593 nucleotides, predicting 530 amino acid residues including a signal peptide. The N-terminal region of the native enzyme underwent further proteolytic modification after processing by a signal peptidase. The protease introduced intermolecular cleavage into an intact single chain botulinum neurotoxin (BoNT) at a specific site. Homology modeling and docking simulation of C-St BoNT and C-St protease demonstrated that the specific nicking-site of the BoNT appears to fit into the deep pocket in the active site of the protease.


Assuntos
Toxinas Botulínicas/metabolismo , Clostridium botulinum/enzimologia , Cisteína Endopeptidases/química , Sequência de Aminoácidos , Sequência de Bases , Toxinas Botulínicas/química , Cátions Bivalentes/química , Cátions Bivalentes/metabolismo , Clostridium botulinum/classificação , Clostridium botulinum/genética , Simulação por Computador , Cisteína Endopeptidases/genética , Cisteína Endopeptidases/isolamento & purificação , Inibidores de Cisteína Proteinase/farmacologia , Metais/química , Metais/metabolismo , Modelos Moleculares , Dados de Sequência Molecular , Conformação Proteica , Sorotipagem , Especificidade por Substrato
3.
FEMS Immunol Med Microbiol ; 54(3): 290-8, 2008 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-18801042

RESUMO

Botulinum neurotoxin (BoNT) is produced as a large toxin complex (L-TC) associated with nontoxic nonhemagglutinin (NTNHA) and three hemagglutinin subcomponents (HA-70, -33 and -17). The binding properties of BoNT to neurons and L-TC to intestinal epithelial cells are well documented, while those to other tissues are largely unknown. Here, to obtain novel insights into the pathogenesis of foodborne botulism, we examine whether botulinum toxins bind to vascular endothelial cells. BoNT and 750 kDa L-TC (a complex of BoNT, NTNHA and HAs) of Clostridium botulinum serotype D were incubated with bovine aortic endothelial cells (BAECs), and binding to the cells was assessed using sodium dodecyl sulfate polyacrylamide gel electrophoresis and Western blot. Both BoNT and L-TC bound to BAECs, with L-TC showing stronger binding. Binding of BoNT and L-TC to BAECs was significantly inhibited by N-acetyl neuraminic acid in the cell culture medium or by treatment of the cells with neuraminidase. However, galactose, lactose or N-acetyl galactosamine did not significantly inhibit toxin binding to the cells. This is the first report demonstrating that BoNT and L-TC bind to BAECs via sialic acid, and this mechanism may be important in the trafficking pathway of BoNT in foodborne botulism.


Assuntos
Toxinas Botulínicas/metabolismo , Clostridium botulinum tipo D/patogenicidade , Células Endoteliais/metabolismo , Ácido N-Acetilneuramínico/metabolismo , Neurotoxinas/metabolismo , Animais , Aorta/citologia , Toxinas Botulínicas/química , Bovinos , Células Cultivadas , Clostridium botulinum tipo D/metabolismo , Endotélio Vascular/citologia , Endotélio Vascular/metabolismo , Hemaglutininas/química , Hemaglutininas/metabolismo , Neurotoxinas/química
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA